Fluidigm to Participate in the 31st Annual Piper Jaffray Healthcare Conference
13 nov. 2019 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Announces Conference Call and Webcast of Third Quarter 2019 Financial Results
10 oct. 2019 16h10 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Becomes the First Company to Enable 50-Plex Cytometry Panels with the Release of Seven New Metal Antibody Labels
24 sept. 2019 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
CyTOF Inventors Receive Prestigious Science and Technology Award from the Human Proteome Organization (HUPO)
18 sept. 2019 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Human Proteome Organization (HUPO), an international scientific organization that promotes proteomics through international...
Fluidigm Files Patent Infringement Suit Against IONpath
10 sept. 2019 07h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm to Participate in Upcoming Health Care Investor Conferences
20 août 2019 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
CORRECTING and REPLACING - Fluidigm Announces Second Quarter 2019 Financial Results
02 août 2019 00h41 HE
|
Fluidigm Corporation
Second Quarter Revenue Increased 7 Percent to $28.2 Million Mass Cytometry Revenue Growth of 28 Percent in Second Quarter Expansion of Mass Cytometry Products with New Metal Markers and Imaging Mass...
Fluidigm Announces Second Quarter 2019 Financial Results
01 août 2019 16h05 HE
|
Fluidigm Corporation
Second Quarter Revenue Increased 7 Percent to $28.2 Million Mass Cytometry Revenue Growth of 28 Percent in Second Quarter Expansion of Mass Cytometry Products with New Metal Markers and Imaging Mass...
Fluidigm Announces Conference Call and Webcast of Second Quarter 2019 Financial Results
03 juil. 2019 13h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 03, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Highlights New Advancements in Deep Cellular Profiling from Circulation to Tissue at CYTO 2019
20 juin 2019 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...